Status:
COMPLETED
Study for Improving Maternal, Pregnancy and Child Outcomes
Lead Sponsor:
Uppsala University
Collaborating Sponsors:
Thermo Fisher Scientific, Inc
Perkin Elmer Inc.
Conditions:
Pre-Eclampsia
Eligibility:
FEMALE
18+ years
Brief Summary
The overall aims of this proposal are to improve, facilitate, optimize and equalize the existing screening system for adverse pregnancy outcomes in early pregnancy in order to limit adverse consequenc...
Detailed Description
Preeclampsia is a pregnancy-specific syndrome that affects 3-5% of all pregnancies and traditionally defined as new onset hypertension (blood pressure ≥ 140/90) and proteinuria after gestational week ...
Eligibility Criteria
Inclusion
- Women with a Swedish personal identity number, who adhere to maternal care program before the end of the first trimester and have a planned first trimester scan (weeks 11-13) are eligible for the study.
Exclusion
- Maternal age \<18 years or language-barrier despite interpreter and written information.
Key Trial Info
Start Date :
November 9 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2022
Estimated Enrollment :
13000 Patients enrolled
Trial Details
Trial ID
NCT03831490
Start Date
November 9 2018
End Date
December 31 2022
Last Update
May 9 2024
Active Locations (9)
Enter a location and click search to find clinical trials sorted by distance.
1
Eskilstuna hospital
Eskilstuna, Sörmland, Sweden
2
Södra Älvsborgs sjukhus
Borås, Västra Götalandsregionen, Sweden
3
Norra Älvsborgs sjukhus
Trollhättan, Västra Götalandsregionen, Sweden
4
County Council Dalarna
Falun, Sweden